{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:03:13Z","timestamp":1788454993371,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jocn.2020.03.010","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T08:28:19Z","timestamp":1584952099000},"page":"176-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Evidence of altered Th17 pathway signatures in the cerebrospinal fluid of patients with Guillain Barr\u00e9 Syndrome"],"prefix":"10.1016","volume":"75","author":[{"given":"Monojit","family":"Debnath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Nagappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debprasad","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinku Mani","family":"Talukdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Subbanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkataram","family":"Shivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Wahatule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjib","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parayil Sankaran","family":"Bindu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundar","family":"Periyavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.S.","family":"Umamaheswara Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malathi Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun B.","family":"Taly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2020.03.010_b0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain-Barre syndrome: a true case of molecular mimicry","volume":"25","author":"Ang","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jocn.2020.03.010_b0010","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/brain\/awg207","article-title":"Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndrome","volume":"126","author":"Wanschitz","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2020.03.010_b0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10875-013-9965-3","article-title":"Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barre syndrome","volume":"34","author":"Han","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jocn.2020.03.010_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/ecn.2019.0424","article-title":"Autoimmunity and cytokines in Guillain-Barre syndrome revisited: review of pathomechanisms with an eye on therapeutic options","volume":"30","author":"Ebrahim Soltani","year":"2019","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jocn.2020.03.010_b0025","first-page":"125","article-title":"Cerebrospinal fluid findings in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathies","volume":"146","author":"Illes","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jocn.2020.03.010_b0030","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1074\/mcp.M115.056036","article-title":"The pathogenesis of the demyelinating form of Guillain-Barre syndrome (GBS): proteo-peptidomic and immunological profiling of physiological fluids","volume":"15","author":"Ziganshin","year":"2016","journal-title":"Mol Cell Proteom"},{"key":"10.1016\/j.jocn.2020.03.010_b0035","first-page":"288","article-title":"An appraisal of blood-cerebrospinal fluid barrier dysfunction during the course of Guillain Barre syndrome","volume":"57","author":"Gonzalez-Quevedo","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2020.03.010_b0040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10072-012-1092-z","article-title":"Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barre syndrome","volume":"34","author":"Wang","year":"2013","journal-title":"Neurological Sci"},{"key":"10.1016\/j.jocn.2020.03.010_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/639712","article-title":"Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barre syndrome","volume":"2013","author":"Li","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jocn.2020.03.010_b0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2018.08.001","article-title":"Th17 pathway signatures in a large Indian cohort of Guillain Barre syndrome","volume":"323","author":"Debnath","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2020.03.010_b0055","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/740947","article-title":"Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barre syndrome and downregulated by IVIg treatments","volume":"2014","author":"Li","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jocn.2020.03.010_b0060","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/260473","article-title":"IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barre syndrome","volume":"2012","author":"Li","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"Suppl","key":"10.1016\/j.jocn.2020.03.010_b0065","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barre syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2020.03.010_b0070","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","article-title":"Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies","volume":"72","author":"Merkies","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2020.03.010_b0075","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma exchange\/Sandoglobulin Guillain-Barre Syndrome Trial Group","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2020.03.010_b0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","article-title":"Electrophysiological diagnosis of Guillain-Barre syndrome subtype: could a single study suffice?","volume":"86","author":"Rajabally","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2020.03.010_b0085","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00005072-199810000-00001","article-title":"Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis","volume":"57","author":"Weller","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jocn.2020.03.010_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1096-9896(200105)194:1<1::AID-PATH871>3.0.CO;2-M","article-title":"How well does the CSF inform upon pathology in the brain in Creutzfeldt-Jakob and Alzheimer\u2019s diseases?","volume":"194","author":"Weller","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.jocn.2020.03.010_b0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1024532715775","article-title":"Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"23","author":"Press","year":"2003","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jocn.2020.03.010_b0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2010.05.005","article-title":"The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barre syndrome from chronic inflammatory demyelinating polyneuropathy","volume":"51","author":"Sainaghi","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.jocn.2020.03.010_b0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3389\/fnins.2019.00717","article-title":"Peripheral blood and cerebrospinal fluid cytokine levels in Guillain Barre syndrome: a systematic review and meta-analysis","volume":"13","author":"Sun","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jocn.2020.03.010_b0110","first-page":"5177","article-title":"Identification of CSF biomarkers by proteomics in Guillain-Barre syndrome","volume":"15","author":"Li","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jocn.2020.03.010_b0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/sji.12201","article-title":"Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis","volume":"80","author":"Wang","year":"2014","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jocn.2020.03.010_b0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cyto.2018.04.026","article-title":"Comprehensive cytokine profiling provides evidence for a multi-lineage Th responses in Guillain Barre Syndrome","volume":"110","author":"Debnath","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.jocn.2020.03.010_b0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-5728(93)90284-6","article-title":"Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"47","author":"Maimone","year":"1993","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2020.03.010_b0130","doi-asserted-by":"crossref","first-page":"18460","DOI":"10.1073\/pnas.0809850105","article-title":"IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells","volume":"105","author":"Korn","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.jocn.2020.03.010_b0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jocn.2020.03.010_b0140","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.178.8.4901","article-title":"Stat3 and Stat4 direct development of IL-17-secreting Th cells","volume":"178","author":"Mathur","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2020.03.010_b0145","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","article-title":"STAT3 regulates cytokine-mediated generation of inflammatory helper T cells","volume":"282","author":"Yang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jocn.2020.03.010_b0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1517\/14728222.2016.1086751","article-title":"Are Th17 cells and their cytokines a therapeutic target in Guillain-Barre syndrome?","volume":"20","author":"Wu","year":"2016","journal-title":"Expert Opin Ther Targets"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820300114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820300114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:21:22Z","timestamp":1760822482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586820300114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":30,"alternative-id":["S0967586820300114"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2020.03.010","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence of altered Th17 pathway signatures in the cerebrospinal fluid of patients with Guillain Barr\u00e9 Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2020.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}